XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance beginning of period (in shares) at Dec. 31, 2020   71,998,654      
Balance beginning of period at Dec. 31, 2020 $ 1,738,863 $ 72 $ 5,566,902 $ (3,815,662) $ (12,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (100)     (100)  
Unrealized gain on derivatives 1,893       1,893
Reclassification to interest expense, net 1,017       1,017
Reclassification to equity in earnings of unconsolidated entities 31       31
Distributions declared (14,065)     (14,065)  
Stock-based compensation, net 1,383   1,383    
Balance end of period (in shares) at Mar. 31, 2021   71,998,654      
Balance end of period at Mar. 31, 2021 1,729,022 $ 72 5,568,285 (3,829,827) (9,508)
Balance beginning of period (in shares) at Dec. 31, 2021   67,344,374      
Balance beginning of period at Dec. 31, 2021 1,571,552 $ 67 5,452,550 (3,876,743) (4,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 9,501     9,501  
Unrealized gain on derivatives 15,406       15,406
Reclassification to interest expense, net 1,003       1,003
Reclassification to equity in earnings of unconsolidated entities 22       22
Distributions declared (13,828)     (13,828)  
Stock-based compensation, net (in shares)   44,329      
Stock-based compensation, net 550   550    
Balance end of period (in shares) at Mar. 31, 2022   67,388,703      
Balance end of period at Mar. 31, 2022 $ 1,584,206 $ 67 $ 5,453,100 $ (3,881,070) $ 12,109